Results 121 to 130 of about 114,018,569 (202)

Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma. [PDF]

Cancer Rep (Hoboken)
Nakhaei A, Taghavi A, Afshari AR, Davoudi F, Gheybi E, Jalili-Nik M.   +5 more
europepmc   +1 more source

Culture Dimensionality Modulates Gallium Maltolate Response in Glioblastoma: Comparative Analyses in 2D and 3D Models. [PDF]

Mol Pharm
Szeliska P, Jaroch K, Wróblewska W, Kaźmierski Ł, Maj M, Bojko B.   +5 more
europepmc   +1 more source

The intersection of chemokine signaling with the hallmarks of cancer in glioblastoma. [PDF]

J Neurooncol
Chojak R, Turunen JR, Drewes NB, Koutah L, Fares J, Chen RX, Du R, Faisal UH, Kazi HA, Kelley C, Miska J, Heimberger AB, Ahmed AU, Lesniak MS.   +13 more
europepmc   +1 more source

Cellular Knockdown of SELENOM Promotes Apoptosis Induction in Human Glioblastoma (A-172) Cells via Redox Imbalance

BIOCELL
Egor A. Turovsky, Elena G. Varlamova
openaire   +1 more source

Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from <i>Raja porosa</i>. [PDF]

Mar Drugs
Bauer M, Szeleszczuk Ł, Velmurugan BK, Chiang SL, Laskowska AK, Pisklak DM, Szűcs E, Gombos D, Kamysz W, Fehér T, Pielaszkiewicz N, Małek K, Kleczkowska P.   +12 more
europepmc   +1 more source

Design of a Drug Delivery System for the Localized Treatment of Resected Glioblastoma

reservedDesign of a Drug Delivery System for the Localized Treatment of Resected Glioblastoma Glioblastoma (GBM), a grade 4 glioma, is the most common primary malignant brain tumor in adults..
CAMDZIC, JELENA
core  

IRAK4 Regulates NF-κB signaling to suppress CD8 + T cell activity and promote immune evasion in glioblastoma development. [PDF]

Cancer Immunol Immunother
Xue Z, Song Z, Mo L, Shi L, Yang S.
europepmc   +1 more source

PARP Inhibitors as Radiosensitizers: Current Evidence and Future Directions. [PDF]

Curr Oncol Rep
Pereira E, Pereira F, Campos G, Abrantes AM, Botelho MF, Silva-Vaz P, Pires AS.   +6 more
europepmc   +1 more source

ENHANCING GLIOBLASTOMA THERAPY: COMBINING DEEP LEARNING SEGMENTATION WITH ROBOTIC HISTOTRIPSY

Glioblastoma multiforme (GBM) is the most aggressive and prevalent adult brain cancer, with a median survival of 14 months due to its rapid growth, invasiveness, and resistance to conventional treatments.
Dorosti, Shadi
core  

How survival time reshapes prognostic risk in giant cell glioblastoma. [PDF]

Discov Oncol
Zhang X, Xia J, Huang H, Tu C, Yang Z.
europepmc   +1 more source